Diagnostics and cardiac healthcare

The Fogarty Institute for Innovation is where medical innovation happens and where companies that solve some of the most critical health issues are born. Since beginning operations in late 2007, we have provided support to more than 20 innovative entrepreneurs. Our innovators-in-residence are in various stages of development, and all are moving toward independence with astounding speed and efficiency.

Company Technology Patient Benefit
CyberHeart The startup is developing the first non-invasive software that allows cardiologists to treat cardiac arrhythmias, such as atrial fibrillation, in an outpatient setting and without anesthesia. Arrhythmias affect millions of people worldwide.

View company flyer
The technology developed can treat a variety of arrhythmias and cardiovascular applications, including hypertension.
EchoPixel Created True 3D (t3D) a medical visualization software solution that enables physicians to uniquely visualize and interact with image data depicting tissue and organs as if they were real physical objects. The software gives surgeons an interactive, 3D view inside the human body, before making any incisions.

View company flyer
Building a new world of patient care by providing visualization solutions that enable doctors to work with patient specific body parts instead of images.
G-Tech Medical

New Press Release

Developing a non-invasive wireless, wearable disposable electrode patch to measure the electrical activity from the stomach, small intestine and colon. "An EKG for the gut," the device could precede or complement CT-scans and colonoscopies for early diagnosis of gastrointestinal disorders.

View company flyer
Once applied the technology will allow immediately the implementation of appropriate therapeutic options rather than spending months/years of additional testing trying to rule out other serious conditions.
Zebra Medical Technologies Developed the world's first clinical microscope utilizing multiphoton techniques, delivering real-time imaging systems to researchers investigating the structure and function of skin, muscle, tendon, cartilage, and bone.

View company flyer
By empowering physicians with real-time information to determine cancer margins, we can eliminate the need for costly and time intensive histology sectioning and staining during surgical tumor removal. The patient benefits from accurate, rapid removal of cancer tissue without waiting for lab results; saving significant waiting time at the physician's office and reducing cost to the patient and payers.
Dr. Fogarty

"We strive to create an environment where we can cost effectively develop technology that directly benefits patients."

– Thomas J. Fogarty, MD, Founder, FII